Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1989 Feb;33(2):248–250. doi: 10.1128/aac.33.2.248

Early treatment of Campylobacter jejuni enteritis.

M D Williams 1, J B Schorling 1, L J Barrett 1, S M Dudley 1, I Orgel 1, W C Koch 1, D S Shields 1, S M Thorson 1, J A Lohr 1, R L Guerrant 1
PMCID: PMC171468  PMID: 2818711

Abstract

The bacteriologic and clinical effects of early antibiotic treatment of Campylobacter jejuni enteritis were studied. Erythromycin rapidly eliminated C. jejuni from stools, whereas trimethoprim-sulfamethoxazole did not. Despite its bacteriologic effectiveness, erythromycin did not reduce the duration or severity of diarrhea, abdominal pain, or other symptoms.

Full text

PDF
248

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anders B. J., Lauer B. A., Paisley J. W., Reller L. B. Double-blind placebo controlled trial of erythromycin for treatment of Campylobacter enteritis. Lancet. 1982 Jan 16;1(8264):131–132. doi: 10.1016/s0140-6736(82)90380-4. [DOI] [PubMed] [Google Scholar]
  2. Barada F. A., Jr, Guerrant R. L. Sulfamethoxazole- trimethoprim versus ampicillin in treatment of acute invasive diarrhea in adults. Antimicrob Agents Chemother. 1980 Jun;17(6):961–964. doi: 10.1128/aac.17.6.961. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Blaser M. J., Berkowitz I. D., LaForce F. M., Cravens J., Reller L. B., Wang W. L. Campylobacter enteritis: clinical and epidemiologic features. Ann Intern Med. 1979 Aug;91(2):179–185. doi: 10.7326/0003-4819-91-2-179. [DOI] [PubMed] [Google Scholar]
  4. Blaser M. J., Reller L. B. Campylobacter enteritis. N Engl J Med. 1981 Dec 10;305(24):1444–1452. doi: 10.1056/NEJM198112103052404. [DOI] [PubMed] [Google Scholar]
  5. Blaser M. J., Reller L. B., Luechtefeld N. W., Wang W. L. Campylobacter enteritis in Denver. West J Med. 1982 Apr;136(4):287–290. [PMC free article] [PubMed] [Google Scholar]
  6. DuPont H. L., Ericsson C. D., Robinson A., Johnson P. C. Current problems in antimicrobial therapy for bacterial enteric infection. Am J Med. 1987 Apr 27;82(4A):324–328. [PubMed] [Google Scholar]
  7. Mandal B. K., Ellis M. E., Dunbar E. M., Whale K. Double-blind placebo-controlled trial of erythromycin in the treatment of clinical campylobacter infection. J Antimicrob Chemother. 1984 Jun;13(6):619–623. doi: 10.1093/jac/13.6.619. [DOI] [PubMed] [Google Scholar]
  8. Murray B. J. Campylobacter enteritis. Ann Intern Med. 1983 Jun;98(6):1029–1030. doi: 10.7326/0003-4819-98-6-1029_2. [DOI] [PubMed] [Google Scholar]
  9. Pai C. H., Gillis F., Tuomanen E., Marks M. I. Erythromycin in treatment of Campylobacter enteritis in children. Am J Dis Child. 1983 Mar;137(3):286–288. doi: 10.1001/archpedi.1983.02140290072019. [DOI] [PubMed] [Google Scholar]
  10. Pichler H. E., Diridl G., Stickler K., Wolf D. Clinical efficacy of ciprofloxacin compared with placebo in bacterial diarrhea. Am J Med. 1987 Apr 27;82(4A):329–332. [PubMed] [Google Scholar]
  11. Pitkanen T., Pettersson T., Pomka A., Kosunen T. U. Effect of erythromycin on the fecal excretion of Campylobacter fetus subspecies jejuni. J Infect Dis. 1982 Jan;145(1):128–128. doi: 10.1093/infdis/145.1.128. [DOI] [PubMed] [Google Scholar]
  12. Robins-Browne R. M., Coovadia H. M., Bodasing M. N., Mackenjee M. K. Treatment of acute nonspecific gastroenteritis of infants and young children with erythromycin. Am J Trop Med Hyg. 1983 Jul;32(4):886–890. doi: 10.4269/ajtmh.1983.32.886. [DOI] [PubMed] [Google Scholar]
  13. Vanhoof R., Vanderlinden M. P., Dierickx R., Lauwers S., Yourassowsky E., Butzler J. P. Susceptibility of Campylobacter fetus subsp. jejuni to twenty-nine antimicrobial agents. Antimicrob Agents Chemother. 1978 Oct;14(4):553–556. doi: 10.1128/aac.14.4.553. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES